Beate Rinner

MedicineBiochemistry, Genetics and Molecular BiologyImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Drug combination screening as a translational approach toward an improved drug therapy for chordoma”.

Drug combination screening as a translational approach toward an improved drug therapy for chordoma

Cellular Oncology(2021)10.1007/s13402-021-00632-x

N/A

0DataRank · unranked

10 citations

Michelle Barnard, Birgit Lohberger, Richard Zettl, Iva Brčić, Bernadette Liegl‐Atzwanger +4 more

Novel combinatorial therapy of oncolytic adenovirus AdV5/3-D24-ICOSL-CD40L with anti PD-1 exhibits enhanced anti-cancer efficacy through promotion of intratumoral T-cell infiltration and modulation of tumour microenvironment in mesothelioma mouse model

Frontiers in Oncology(2023)10.3389/fonc.2023.1259314

N/A

0DataRank · unranked

9 citations

Magdalena Wieczorek, Ines Anders, Monika Staniszewska, Michał Łaźniewski, Marta Prygiel +11 more

Priming with oncolytic adenovirus followed by anti-PD-1 and paclitaxel treatment leads to improved anti-cancer efficacy in the 3D TNBC model

European Journal of Pharmaceutics and Biopharmaceutics(2024)10.1016/j.ejpb.2024.114300

N/A

0DataRank · unranked

13 citations

Sara Mathlouthi, Magdalena Wieczorek, Beata Gad, Beate Rinner, Alessio Malfanti +5 more